Global and United States Injectable Drug Delivery Formulation In-Depth Research Report 2017-2022

Published: Dec, 2017 | Pages: 105 | Publisher: US Market Insight (UMI)
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022.

This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Injectable Drug Delivery Formulation industry.

Major Companies
    Becton, Dickinson and Company (U.S.)
    Baxter International Inc. (U.S.)
    Gerresheimer AG (Germany)
    Pfizer, Inc. (U.S.)
    Schott AG (Germany)
    Sandoz (Germany)
    Teva Pharmaceutical Industries Ltd. (Israel)
    Eli Lilly and Company (U.S.)

Key Regions
    North America
        United States
            California
            Texas
            New York
            Others
        Canada
    Latin America
        Mexico
        Brazil
        Argentina
        Others
    Europe
        Germany
        United Kingdom
        France
        Italy
        Spain
        Russia
        Netherland
        Others
    Asia & Pacific
        China
        Japan
        India
        Korea
        Australia
        Southeast Asia
            Indonesia
            Thailand
            Philippines
            Vietnam
            Singapore
            Malaysia
            Others
    Africa & Middle East
        South Africa
        Egypt
        Turkey
        Saudi Arabia
        Iran
        Others

Main types of products
Injectable Drug Delivery Formulation Market, bynventional Drug Delivery Formu
Injectable Drug Delivery Formulation Market, byvel Drug Delivery Formulations
Injectable Drug Delivery Formulation Market, byng-acting Formulations

Injectable Drug Delivery Formulation Market, by Key Consumers
    Autoimmune Diseases
    Hormonal Disorders
    Oncology
    Orphan Diseases
    Others

 Table of Contents

Global and United States Injectable Drug Delivery Formulation In-Depth Research Report 2017-2022
Chapter One Global Injectable Drug Delivery Formulation Market Overview
    1.1 Global Injectable Drug Delivery Formulation Market Sales Volume Revenue and Price 2012-2017
    1.2 Injectable Drug Delivery Formulation, by ventional Drug Delivery Formul 2012-2017
        1.2.1 Global Injectable Drug Delivery Formulation Sales Market Share by ventional Drug Delivery Formul 2012-2017
        1.2.2 Global Injectable Drug Delivery Formulation Revenue Market Share by ventional Drug Delivery Formul 2012-2017
        1.2.3 Global Injectable Drug Delivery Formulation Price by ventional Drug Delivery Formul 2012-2017
        1.2.4 
        1.2.5 
    1.3 Injectable Drug Delivery Formulation, by el Drug Delivery Formulations 2012-2017
        1.3.1 Global Injectable Drug Delivery Formulation Sales Market Share by el Drug Delivery Formulations 2012-2017
        1.3.2 Global Injectable Drug Delivery Formulation Revenue Market Share by el Drug Delivery Formulations 2012-2017
        1.3.3 Global Injectable Drug Delivery Formulation Price by el Drug Delivery Formulations 2012-2017
        1.3.4 
        1.3.5 
    1.4 Injectable Drug Delivery Formulation, by g-acting Formulations 2012-2017
        1.4.1 Global Injectable Drug Delivery Formulation Sales Market Share by g-acting Formulations 2012-2017
        1.4.2 Global Injectable Drug Delivery Formulation Revenue Market Share by g-acting Formulations 2012-2017
        1.4.3 Global Injectable Drug Delivery Formulation Price by g-acting Formulations 2012-2017
        1.4.4 
        1.4.5 

Chapter Two United States Injectable Drug Delivery Formulation Market Overview
    2.1 United States Injectable Drug Delivery Formulation Market Sales Volume Revenue and Price 2012-2017
    2.2 Injectable Drug Delivery Formulation, by ventional Drug Delivery Formul 2012-2017
        2.2.1 United States Injectable Drug Delivery Formulation Sales Market Share by ventional Drug Delivery Formul 2012-2017
        2.2.2 United States Injectable Drug Delivery Formulation Revenue Market Share by ventional Drug Delivery Formul 2012-2017
        2.2.3 United States Injectable Drug Delivery Formulation Price by ventional Drug Delivery Formul 2012-2017
        2.2.4 
        2.2.5 
    2.3 Injectable Drug Delivery Formulation, by el Drug Delivery Formulations 2012-2017
        2.3.1 United States Injectable Drug Delivery Formulation Sales Market Share by el Drug Delivery Formulations 2012-2017
        2.3.2 United States Injectable Drug Delivery Formulation Revenue Market Share by el Drug Delivery Formulations 2012-2017
        2.3.3 United States Injectable Drug Delivery Formulation Price by el Drug Delivery Formulations 2012-2017
        2.3.4 
        2.3.5 
    2.4 Injectable Drug Delivery Formulation, by g-acting Formulations 2012-2017
        2.4.1 United States Injectable Drug Delivery Formulation Sales Market Share by g-acting Formulations 2012-2017
        2.4.2 United States Injectable Drug Delivery Formulation Revenue Market Share by g-acting Formulations 2012-2017
        2.4.3 United States Injectable Drug Delivery Formulation Price by g-acting Formulations 2012-2017
        2.4.4 
        2.4.5 

Chapter Three Injectable Drug Delivery Formulation by Regions 2012-2017
    3.1 Global Injectable Drug Delivery Formulation Sales Market Share by Regions 2012-2017
    3.2 Global Injectable Drug Delivery Formulation Revenue Market Share by Regions 2012-2017
    3.3 Global Injectable Drug Delivery Formulation Price by Regions 2012-2017
    3.4 North America
        3.4.1 United States
            3.4.1.1 California
            3.4.1.2 Texas
            3.4.1.3 New York
            3.4.1.4 Others in United States
        3.4.2 Canada
    3.5 Latin America
        3.5.1 Mexico
        3.5.2 Brazil
        3.5.3 Argentina
        3.5.4 Others in Latin America
    3.6 Europe
        3.6.1 Germany
        3.6.2 United Kingdom
        3.6.3 France
        3.6.4 Italy
        3.6.5 Spain
        3.6.6 Russia
        3.6.7 Netherland
        3.6.8 Others in Europe
    3.7 Asia & Pacific
        3.7.1 China
        3.7.2 Japan
        3.7.3 India
        3.7.4 Korea
        3.7.5 Australia
        3.7.6 Southeast Asia
            3.7.6.1 Indonesia
            3.7.6.2 Thailand
            3.7.6.3 Philippines
            3.7.6.4 Vietnam
            3.7.6.5 Singapore
            3.7.6.6 Malaysia
            3.7.6.7 Others in Southeast Asia
    3.8 Africa & Middle East
        3.8.1 South Africa
        3.8.2 Egypt
        3.8.3 Turkey
        3.8.4 Saudi Arabia
        3.8.5 Iran
        3.8.6 Others in Africa & Middle East

Chapter Four Global Injectable Drug Delivery Formulation by Companies 2012-2017
    4.1 Global Injectable Drug Delivery Formulation Sales Volume Market Share by Companies 2012-2017
    4.2 Global Injectable Drug Delivery Formulation Revenue Share by Companies 2012-2017
    4.3 Global Top Companies Injectable Drug Delivery Formulation Key Product Model and Market Performance
    4.4 Global Top Companies Injectable Drug Delivery Formulation Key Target Consumers and Market Performance

Chapter Five United States Injectable Drug Delivery Formulation by Companies 2012-2017
    5.1 United States Injectable Drug Delivery Formulation Sales Volume Market Share by Companies 2012-2017
    5.2 United States Injectable Drug Delivery Formulation Revenue Share by Companies 2012-2017
    5.3 United States Top Companies Injectable Drug Delivery Formulation Key Product Model and Market Performance
    5.4 United States Top Companies Injectable Drug Delivery Formulation Key Target Consumers and Market Performance

Chapter Six Global Injectable Drug Delivery Formulation by Consumer 2012-2017
    6.1 Global Injectable Drug Delivery Formulation Sales Market Share by Consumer 2012-2017
    6.2 Autoimmune Diseases
    6.3 Hormonal Disorders
    6.4 Oncology
    6.5 Orphan Diseases
    6.6 Others
    6.7 Consuming Habit and Preference

Chapter Seven Global Injectable Drug Delivery Formulation by Consumer 2012-2017
    7.1 Global Injectable Drug Delivery Formulation Sales Market Share by Consumer 2012-2017
    7.2 Autoimmune Diseases
    7.3 Hormonal Disorders
    7.4 Oncology
    7.5 Orphan Diseases
    7.6 Others
    7.7 Consuming Habit and Preference

Chapter Eight Top Companies Profile
    8.1 Becton, Dickinson and Company (U.S.)
        8.1.1 Becton, Dickinson and Company (U.S.) Company Details and Competitors
        8.1.2 Becton, Dickinson and Company (U.S.) Key Injectable Drug Delivery Formulation Models and Performance
        8.1.3 Becton, Dickinson and Company (U.S.) Injectable Drug Delivery Formulation Business SWOT Analysis and Forecast
        8.1.4 Becton, Dickinson and Company (U.S.) Injectable Drug Delivery Formulation Sales Volume Revenue Price Cost and Gross Margin
    8.2 Baxter International Inc. (U.S.)
        8.2.1 Baxter International Inc. (U.S.) Company Details and Competitors
        8.2.2 Baxter International Inc. (U.S.) Key Injectable Drug Delivery Formulation Models and Performance
        8.2.3 Baxter International Inc. (U.S.) Injectable Drug Delivery Formulation Business SWOT Analysis and Forecast
        8.2.4 Baxter International Inc. (U.S.) Injectable Drug Delivery Formulation Sales Volume Revenue Price Cost and Gross Margin
    8.3 Gerresheimer AG (Germany)
        8.3.1 Gerresheimer AG (Germany) Company Details and Competitors
        8.3.2 Gerresheimer AG (Germany) Key Injectable Drug Delivery Formulation Models and Performance
        8.3.3 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Business SWOT Analysis and Forecast
        8.3.4 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales Volume Revenue Price Cost and Gross Margin
    8.4 Pfizer, Inc. (U.S.)
        8.4.1 Pfizer, Inc. (U.S.) Company Details and Competitors
        8.4.2 Pfizer, Inc. (U.S.) Key Injectable Drug Delivery Formulation Models and Performance
        8.4.3 Pfizer, Inc. (U.S.) Injectable Drug Delivery Formulation Business SWOT Analysis and Forecast
        8.4.4 Pfizer, Inc. (U.S.) Injectable Drug Delivery Formulation Sales Volume Revenue Price Cost and Gross Margin
    8.5 Schott AG (Germany)
        8.5.1 Schott AG (Germany) Company Details and Competitors
        8.5.2 Schott AG (Germany) Key Injectable Drug Delivery Formulation Models and Performance
        8.5.3 Schott AG (Germany) Injectable Drug Delivery Formulation Business SWOT Analysis and Forecast
        8.5.4 Schott AG (Germany) Injectable Drug Delivery Formulation Sales Volume Revenue Price Cost and Gross Margin
    8.6 Sandoz (Germany)
        8.6.1 Sandoz (Germany) Company Details and Competitors
        8.6.2 Sandoz (Germany) Key Injectable Drug Delivery Formulation Models and Performance
        8.6.3 Sandoz (Germany) Injectable Drug Delivery Formulation Business SWOT Analysis and Forecast
        8.6.4 Sandoz (Germany) Injectable Drug Delivery Formulation Sales Volume Revenue Price Cost and Gross Margin
    8.7 Teva Pharmaceutical Industries Ltd. (Israel)
        8.7.1 Teva Pharmaceutical Industries Ltd. (Israel) Company Details and Competitors
        8.7.2 Teva Pharmaceutical Industries Ltd. (Israel) Key Injectable Drug Delivery Formulation Models and Performance
        8.7.3 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Business SWOT Analysis and Forecast
        8.7.4 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales Volume Revenue Price Cost and Gross Margin
    8.8 Eli Lilly and Company (U.S.)
        8.8.1 Eli Lilly and Company (U.S.) Company Details and Competitors
        8.8.2 Eli Lilly and Company (U.S.) Key Injectable Drug Delivery Formulation Models and Performance
        8.8.3 Eli Lilly and Company (U.S.) Injectable Drug Delivery Formulation Business SWOT Analysis and Forecast
        8.8.4 Eli Lilly and Company (U.S.) Injectable Drug Delivery Formulation Sales Volume Revenue Price Cost and Gross Margin

Chapter Nine Industry Chain and Supply Chain
    9.1 Injectable Drug Delivery Formulation Industry Chain Structure
        9.1.1 R&D
        9.1.2 Raw Materials (Components)
        9.1.3 Manufacturing Plants
        9.1.4 Regional Trading (Import Export and Local Sales)
        9.1.5 Online Sales Channel
        9.1.6 Offline Channel
        9.1.7 End Users
    9.2 Injectable Drug Delivery Formulation Manufacturing
        9.2.1 Key Components
        9.2.2 Assembly Manufacturing
    9.3 Consumer Preference
    9.4 Behavioral Habits
    9.5 Marketing Environment

Chapter Ten Global Injectable Drug Delivery Formulation Market Size (Sales and Revenue) Forecast (2017-2022)
    10.1 Global Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
    10.2 Global Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by Regions (2017-2022)
    10.3 Global Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by Application (2017-2022)
    10.4 Global Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by ventional Drug Delivery Formul (2017-2022)
    10.5 Global Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by el Drug Delivery Formulations (2017-2022)
    10.6 Global Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by g-acting Formulations (2017-2022)

Chapter Eleven United States Injectable Drug Delivery Formulation Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 United States Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
    11.2 United States Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by Regions (2017-2022)
    11.3 United States Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by Application (2017-2022)
    11.4 United States Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by ventional Drug Delivery Formul (2017-2022)
    11.5 United States Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by el Drug Delivery Formulations (2017-2022)
    11.6 United States Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by g-acting Formulations (2017-2022)

Chapter Twelve Development Trend and Research Conclusion
    12.1 Development Trend
    12.2 Research Conclusion

Chapter Thirteen Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer

List of Tables and Figures

    Table Global Injectable Drug Delivery Formulation Sales Volume (K Pcs), Revenue (Million USD) and Price (USD/Pcs)(2012-2017)
    Figure Global Injectable Drug Delivery Formulation Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Global Injectable Drug Delivery Formulation Sales Volume (K Pcs) and Growth Rate (2012-2017)
    Table Global Injectable Drug Delivery Formulation Sales (K Pcs) by ventional Drug Delivery Formul (2012-2017)
    Table Global Injectable Drug Delivery Formulation Sales Market Share by ventional Drug Delivery Formul (2012-2017)
    Figure Global Injectable Drug Delivery Formulation Sales Market Share by ventional Drug Delivery Formul in 2016
    Table Global Injectable Drug Delivery Formulation Revenue (Million USD) by ventional Drug Delivery Formul (2012-2017)
    Table Global Injectable Drug Delivery Formulation Revenue Market Share by ventional Drug Delivery Formul (2012-2017)
    Figure Global Injectable Drug Delivery Formulation Revenue Market Share by ventional Drug Delivery Formul in 2016
    Table Global Injectable Drug Delivery Formulation Price (USD/Pcs) by ventional Drug Delivery Formul (2012-2017)
    Table Global Injectable Drug Delivery Formulation Sales (K Pcs) by el Drug Delivery Formulations (2012-2017)
    Table Global Injectable Drug Delivery Formulation Sales Market Share by el Drug Delivery Formulations (2012-2017)
    Figure Global Injectable Drug Delivery Formulation Sales Market Share by el Drug Delivery Formulations in 2016
    Table Global Injectable Drug Delivery Formulation Revenue (Million USD) by el Drug Delivery Formulations (2012-2017)
    Table Global Injectable Drug Delivery Formulation Revenue Market Share by el Drug Delivery Formulations (2012-2017)
    Figure Global Injectable Drug Delivery Formulation Revenue Market Share by el Drug Delivery Formulations in 2016
    Table Global Injectable Drug Delivery Formulation Price (USD/Pcs) by el Drug Delivery Formulations (2012-2017)
    Table Global Injectable Drug Delivery Formulation Sales (K Pcs) by g-acting Formulations (2012-2017)
    Table Global Injectable Drug Delivery Formulation Sales Market Share by g-acting Formulations (2012-2017)
    Figure Global Injectable Drug Delivery Formulation Sales Market Share by g-acting Formulations in 2016
    Table Global Injectable Drug Delivery Formulation Revenue (Million USD) by g-acting Formulations (2012-2017)
    Table Global Injectable Drug Delivery Formulation Revenue Market Share by g-acting Formulations (2012-2017)
    Figure Global Injectable Drug Delivery Formulation Revenue Market Share by g-acting Formulations in 2016
    Table Global Injectable Drug Delivery Formulation Price (USD/Pcs) by g-acting Formulations (2012-2017)
    Figure United States Injectable Drug Delivery Formulation Revenue (Million USD) and Growth Rate (2012-2017)
    Figure United States Injectable Drug Delivery Formulation Sales Volume (K Pcs) and Growth Rate (2012-2017)
    Table United States Injectable Drug Delivery Formulation Sales (K Pcs) by ventional Drug Delivery Formul (2012-2017)
    Table United States Injectable Drug Delivery Formulation Sales Market Share by ventional Drug Delivery Formul (2012-2017)
    Figure United States Injectable Drug Delivery Formulation Sales Market Share by ventional Drug Delivery Formul in 2016
    Table United States Injectable Drug Delivery Formulation Revenue (Million USD) by ventional Drug Delivery Formul (2012-2017)
    Table United States Injectable Drug Delivery Formulation Revenue Market Share by ventional Drug Delivery Formul (2012-2017)
    Figure United States Injectable Drug Delivery Formulation Revenue Market Share by ventional Drug Delivery Formul in 2016
    Table United States Injectable Drug Delivery Formulation Price (USD/Pcs) by ventional Drug Delivery Formul (2012-2017)
    Table United States Injectable Drug Delivery Formulation Sales (K Pcs) by el Drug Delivery Formulations (2012-2017)
    Table United States Injectable Drug Delivery Formulation Sales Market Share by el Drug Delivery Formulations (2012-2017)
    Figure United States Injectable Drug Delivery Formulation Sales Market Share by el Drug Delivery Formulations in 2016
    Table United States Injectable Drug Delivery Formulation Revenue (Million USD) by el Drug Delivery Formulations (2012-2017)
    Table United States Injectable Drug Delivery Formulation Revenue Market Share by el Drug Delivery Formulations (2012-2017)
    Figure United States Injectable Drug Delivery Formulation Revenue Market Share by el Drug Delivery Formulations in 2016
    Table United States Injectable Drug Delivery Formulation Price (USD/Pcs) by el Drug Delivery Formulations (2012-2017)
    Table United States Injectable Drug Delivery Formulation Sales (K Pcs) by g-acting Formulations (2012-2017)
    Table United States Injectable Drug Delivery Formulation Sales Market Share by g-acting Formulations (2012-2017)
    Figure United States Injectable Drug Delivery Formulation Sales Market Share by g-acting Formulations in 2016
    Table United States Injectable Drug Delivery Formulation Revenue (Million USD) by g-acting Formulations (2012-2017)
    Table United States Injectable Drug Delivery Formulation Revenue Market Share by g-acting Formulations (2012-2017)
    Figure United States Injectable Drug Delivery Formulation Revenue Market Share by g-acting Formulations in 2016
    Table United States Injectable Drug Delivery Formulation Price (USD/Pcs) by g-acting Formulations (2012-2017)
    Table Global Injectable Drug Delivery Formulation Sales (K Pcs) by Regions (2012-2017)
    Table Global Injectable Drug Delivery Formulation Sales Share by Regions (2012-2017)
    Figure Global Injectable Drug Delivery Formulation Sales Market Share by Regions in 2016
    Figure Global Injectable Drug Delivery Formulation Sales Market Share by Regions in 2017
    Table Global Injectable Drug Delivery Formulation Revenue (Million USD) and Market Share by Regions (2012-2017)
    Table Global Injectable Drug Delivery Formulation Revenue Market Share by Regions (2012-2017)
    Figure Global Injectable Drug Delivery Formulation Revenue Market Share by Regions in 2016
    Figure Global Injectable Drug Delivery Formulation Revenue Market Share by Regions in 2017
    Table Global Injectable Drug Delivery Formulation Price (USD/Pcs) by Regions (2012-2017)
    Table North America Injectable Drug Delivery Formulation Sales (K Pcs) by Regions (2012-2017)
    Table North America Injectable Drug Delivery Formulation Revenue (Million USD) by Regions (2012-2017)
    Figure North America Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (2012-2017)
    Table United States Injectable Drug Delivery Formulation Sales (K Pcs) by Regions (2012-2017)
    Table United States Injectable Drug Delivery Formulation Revenue (Million USD) by Regions (2012-2017)
    Figure United States Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (2012-2017)
    Table Latin America Injectable Drug Delivery Formulation Sales (K Pcs) by Regions (2012-2017)
    Table Latin America Injectable Drug Delivery Formulation Revenue (Million USD) by Regions (2012-2017)
    Figure Latin America Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (2012-2017)
    Table Europe Injectable Drug Delivery Formulation Sales (K Pcs) by Regions (2012-2017)
    Table Europe Injectable Drug Delivery Formulation Revenue (Million USD) by Regions (2012-2017)
    Figure Europe Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (2012-2017)
    Table Asia & Pacific Injectable Drug Delivery Formulation Sales (K Pcs) by Regions (2012-2017)
    Table Asia & Pacific Injectable Drug Delivery Formulation Revenue (Million USD) by Regions (2012-2017)
    Figure Asia & Pacific Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (2012-2017)
    Table Africa & Middle East Injectable Drug Delivery Formulation Sales (K Pcs) by Regions (2012-2017)
    Table Africa & Middle East Injectable Drug Delivery Formulation Revenue (Million USD) by Regions (2012-2017)
    Figure Africa & Middle East Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (2012-2017)
    Table Global Injectable Drug Delivery Formulation Sales Volume (K Pcs) by Major Companies (2012-2017)
    Table Global Injectable Drug Delivery Formulation Sales Volume Market Share by Major Companies (2012-2017)
    Figure Global Injectable Drug Delivery Formulation Sales Volume Market Share by Major Companies 2016
    Figure Global Injectable Drug Delivery Formulation Sales Volume Market Share by Major Companies 2017
    Table Global Injectable Drug Delivery Formulation Revenue (Million USD) by Major Companies (2012-2017)
    Table Global Injectable Drug Delivery Formulation Revenue Market Share by Major Companies (2012-2017)
    Figure Global Injectable Drug Delivery Formulation Revenue Market Share by Major Companies 2016
    Figure Global Injectable Drug Delivery Formulation Revenue Market Share by Major Companies 2017
    Table Global Top Companies Key Product Model and Market Performance
    Table Global Top Companies Key Target Consumers and Market Performance
    Table United States Injectable Drug Delivery Formulation Sales Volume (K Pcs) by Top Companies (2012-2017)
    Table United States Injectable Drug Delivery Formulation Sales Volume Market Share by Top Companies (2012-2017)
    Figure United States Injectable Drug Delivery Formulation Sales Volume Market Share by Top Companies 2016
    Figure United States Injectable Drug Delivery Formulation Sales Volume Market Share by Top Companies 2017
    Table United States Injectable Drug Delivery Formulation Revenue (Million USD) by Top Companies (2012-2017)
    Table United States Injectable Drug Delivery Formulation Revenue Market Share by Top Companies (2012-2017)
    Figure United States Injectable Drug Delivery Formulation Revenue Market Share by Top Companies 2016
    Figure United States Injectable Drug Delivery Formulation Revenue Market Share by Top Companies 2017
    Table United States Top Companies Key Product Model and Market Performance
    Table United States Top Companies Key Target Consumers and Market Performance
    Table Global Injectable Drug Delivery Formulation Sales (K Pcs) by Consumer (2012-2017)
    Figure Global Injectable Drug Delivery Formulation Sales Market Share by Consumer (2012-2017)
    Figure Global Injectable Drug Delivery Formulation Sales Market Share by Consumer in 2016
    Figure Global Autoimmune Diseases Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Hormonal Disorders Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Oncology Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Orphan Diseases Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Others Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (2012-2017)
    Table United States Injectable Drug Delivery Formulation Sales (K Pcs) by Consumer (2012-2017)
    Figure United States Injectable Drug Delivery Formulation Sales Market Share by Consumer (2012-2017)
    Figure United States Injectable Drug Delivery Formulation Sales Market Share by Consumer in 2016
    Figure United States Autoimmune Diseases Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (2012-2017)
    Figure United States Hormonal Disorders Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (2012-2017)
    Figure United States Oncology Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (2012-2017)
    Figure United States Orphan Diseases Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (2012-2017)
    Figure United States Others Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (2012-2017)
    Table Becton, Dickinson and Company (U.S.) Company Details and Competitors
    Table Becton, Dickinson and Company (U.S.) Key Injectable Drug Delivery Formulation Models and Performance
    Table Becton, Dickinson and Company (U.S.) Injectable Drug Delivery Formulation Business SWOT Analysis and Forecast
    Table Becton, Dickinson and Company (U.S.) Injectable Drug Delivery Formulation Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Becton, Dickinson and Company (U.S.) Injectable Drug Delivery Formulation Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Becton, Dickinson and Company (U.S.) Injectable Drug Delivery Formulation Sales Market Share (%) in Global (2012-2017)
    Figure Becton, Dickinson and Company (U.S.) Injectable Drug Delivery Formulation Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Becton, Dickinson and Company (U.S.) Injectable Drug Delivery Formulation Revenue Market Share (%) in Global (2012-2017)
    Table Baxter International Inc. (U.S.) Company Details and Competitors
    Table Baxter International Inc. (U.S.) Key Injectable Drug Delivery Formulation Models and Performance
    Table Baxter International Inc. (U.S.) Injectable Drug Delivery Formulation Business SWOT Analysis and Forecast
    Table Baxter International Inc. (U.S.) Injectable Drug Delivery Formulation Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Baxter International Inc. (U.S.) Injectable Drug Delivery Formulation Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Baxter International Inc. (U.S.) Injectable Drug Delivery Formulation Sales Market Share (%) in Global (2012-2017)
    Figure Baxter International Inc. (U.S.) Injectable Drug Delivery Formulation Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Baxter International Inc. (U.S.) Injectable Drug Delivery Formulation Revenue Market Share (%) in Global (2012-2017)
    Table Gerresheimer AG (Germany) Company Details and Competitors
    Table Gerresheimer AG (Germany) Key Injectable Drug Delivery Formulation Models and Performance
    Table Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Business SWOT Analysis and Forecast
    Table Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales Market Share (%) in Global (2012-2017)
    Figure Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Revenue Market Share (%) in Global (2012-2017)
    Table Pfizer, Inc. (U.S.) Company Details and Competitors
    Table Pfizer, Inc. (U.S.) Key Injectable Drug Delivery Formulation Models and Performance
    Table Pfizer, Inc. (U.S.) Injectable Drug Delivery Formulation Business SWOT Analysis and Forecast
    Table Pfizer, Inc. (U.S.) Injectable Drug Delivery Formulation Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Pfizer, Inc. (U.S.) Injectable Drug Delivery Formulation Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Pfizer, Inc. (U.S.) Injectable Drug Delivery Formulation Sales Market Share (%) in Global (2012-2017)
    Figure Pfizer, Inc. (U.S.) Injectable Drug Delivery Formulation Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Pfizer, Inc. (U.S.) Injectable Drug Delivery Formulation Revenue Market Share (%) in Global (2012-2017)
    Table Schott AG (Germany) Company Details and Competitors
    Table Schott AG (Germany) Key Injectable Drug Delivery Formulation Models and Performance
    Table Schott AG (Germany) Injectable Drug Delivery Formulation Business SWOT Analysis and Forecast
    Table Schott AG (Germany) Injectable Drug Delivery Formulation Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Schott AG (Germany) Injectable Drug Delivery Formulation Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Schott AG (Germany) Injectable Drug Delivery Formulation Sales Market Share (%) in Global (2012-2017)
    Figure Schott AG (Germany) Injectable Drug Delivery Formulation Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Schott AG (Germany) Injectable Drug Delivery Formulation Revenue Market Share (%) in Global (2012-2017)
    Table Sandoz (Germany) Company Details and Competitors
    Table Sandoz (Germany) Key Injectable Drug Delivery Formulation Models and Performance
    Table Sandoz (Germany) Injectable Drug Delivery Formulation Business SWOT Analysis and Forecast
    Table Sandoz (Germany) Injectable Drug Delivery Formulation Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Sandoz (Germany) Injectable Drug Delivery Formulation Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Sandoz (Germany) Injectable Drug Delivery Formulation Sales Market Share (%) in Global (2012-2017)
    Figure Sandoz (Germany) Injectable Drug Delivery Formulation Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Sandoz (Germany) Injectable Drug Delivery Formulation Revenue Market Share (%) in Global (2012-2017)
    Table Teva Pharmaceutical Industries Ltd. (Israel) Company Details and Competitors
    Table Teva Pharmaceutical Industries Ltd. (Israel) Key Injectable Drug Delivery Formulation Models and Performance
    Table Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Business SWOT Analysis and Forecast
    Table Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales Market Share (%) in Global (2012-2017)
    Figure Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Revenue Market Share (%) in Global (2012-2017)
    Table Eli Lilly and Company (U.S.) Company Details and Competitors
    Table Eli Lilly and Company (U.S.) Key Injectable Drug Delivery Formulation Models and Performance
    Table Eli Lilly and Company (U.S.) Injectable Drug Delivery Formulation Business SWOT Analysis and Forecast
    Table Eli Lilly and Company (U.S.) Injectable Drug Delivery Formulation Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Eli Lilly and Company (U.S.) Injectable Drug Delivery Formulation Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Eli Lilly and Company (U.S.) Injectable Drug Delivery Formulation Sales Market Share (%) in Global (2012-2017)
    Figure Eli Lilly and Company (U.S.) Injectable Drug Delivery Formulation Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Eli Lilly and Company (U.S.) Injectable Drug Delivery Formulation Revenue Market Share (%) in Global (2012-2017)
    Figure Global Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
    Figure Global Injectable Drug Delivery Formulation Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global Injectable Drug Delivery Formulation Price (USD/Pcs) Trend Forecast (2017-2022)
    Table Global Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by Regions (2017-2022)
    Table Global Injectable Drug Delivery Formulation Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Injectable Drug Delivery Formulation Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Injectable Drug Delivery Formulation Sales Volume Share Forecast by Regions in 2022
    Table Global Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by Application (2017-2022)
    Figure Global Injectable Drug Delivery Formulation Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global Injectable Drug Delivery Formulation Sales Volume Market Share Forecast by Application in 2022
    Table Global Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by ventional Drug Delivery Formul (2017-2022)
    Figure Global Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by ventional Drug Delivery Formul (2017-2022)
    Figure Global Injectable Drug Delivery Formulation Sales Volume Market Share Forecast by ventional Drug Delivery Formul in 2022
    Table Global Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by el Drug Delivery Formulations (2017-2022)
    Figure Global Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by el Drug Delivery Formulations (2017-2022)
    Figure Global Injectable Drug Delivery Formulation Sales Volume Market Share Forecast by el Drug Delivery Formulations in 2022
    Table Global Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by g-acting Formulations (2017-2022)
    Figure Global Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by g-acting Formulations (2017-2022)
    Figure Global Injectable Drug Delivery Formulation Sales Volume Market Share Forecast by g-acting Formulations in 2022
    Figure United States Injectable Drug Delivery Formulation Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
    Figure United States Injectable Drug Delivery Formulation Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure United States Injectable Drug Delivery Formulation Price (USD/Pcs) Trend Forecast (2017-2022)
    Table United States Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by Regions (2017-2022)
    Table United States Injectable Drug Delivery Formulation Sales Volume Share Forecast by Regions (2017-2022)
    Figure United States Injectable Drug Delivery Formulation Sales Volume Share Forecast by Regions (2017-2022)
    Figure United States Injectable Drug Delivery Formulation Sales Volume Share Forecast by Regions in 2022
    Table United States Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by Application (2017-2022)
    Figure United States Injectable Drug Delivery Formulation Sales Volume Market Share Forecast by Application (2017-2022)
    Figure United States Injectable Drug Delivery Formulation Sales Volume Market Share Forecast by Application in 2022
    Table United States Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by ventional Drug Delivery Formul (2017-2022)
    Figure United States Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by ventional Drug Delivery Formul (2017-2022)
    Figure United States Injectable Drug Delivery Formulation Sales Volume Market Share Forecast by ventional Drug Delivery Formul in 2022
    Table United States Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by el Drug Delivery Formulations (2017-2022)
    Figure United States Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by el Drug Delivery Formulations (2017-2022)
    Figure United States Injectable Drug Delivery Formulation Sales Volume Market Share Forecast by el Drug Delivery Formulations in 2022
    Table United States Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by g-acting Formulations (2017-2022)
    Figure United States Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by g-acting Formulations (2017-2022)
    Figure United States Injectable Drug Delivery Formulation Sales Volume Market Share Forecast by g-acting Formulations in 2022